Apollo Hospitals Enterprise Limited
APOLLOHOSP
주식 순위
#1769
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
주가
$83.93
마지막 동기화: 2026-10-21
시가총액
$12.07B
변동 (1일)
-1.23%
변동 (1년)
-7.79%
국가
IN
거래 Apollo Hospitals Enterprise Limited (APOLLOHOSP)
카테고리
Healthcare
Apollo Hospitals Enterprise Limited (APOLLOHOSP)의 매출
Jun 2026 기준 매출 TTM: $2.92B
Apollo Hospitals Enterprise Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $2.92B입니다. 2024년에 회사는 $2.29B의 수익을 올렸으며 이는 2023년의 $2.02B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Apollo Hospitals Enterprise Limited의 수익 기록 (2005 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $2.92B | 14.46% |
| 2025 | $2.55B | 11.48% |
| 2024 | $2.29B | 13.07% |
| 2023 | $2.02B | 4.65% |
| 2022 | $1.93B | 33.90% |
| 2021 | $1.44B | -3.37% |
| 2020 | $1.49B | 7.79% |
| 2019 | $1.39B | 9.39% |
| 2018 | $1.27B | 13.16% |
| 2017 | $1.12B | 19.27% |
| 2016 | $938.06M | 13.03% |
| 2015 | $829.89M | -3.94% |
| 2014 | $863.94M | 23.57% |
| 2013 | $699.16M | 12.64% |
| 2012 | $620.72M | 6.18% |
| 2011 | $584.62M | 29.57% |
| 2010 | $451.20M | 41.91% |
| 2009 | $317.96M | 4.74% |
| 2008 | $303.57M | 38.60% |
| 2007 | $219.03M | 26.76% |
| 2006 | $172.79M | 14.19% |
| 2005 | $151.32M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $78.01B | 2,574.64% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 647.81% |
US
|
|
| $3.89B | 33.53% |
SA
|
|
| $11.08B | 280.04% |
BR
|
